Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective

Immuno-oncologics (IOs) differ from chemotherapies as they prime the patient’s immune system to attack the tumor, rather than directly destroying cancer cells. The IO mechanism of action leads to durable responses and prolonged survival in some patients. However, providing robust evidence of the lon...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Immunother Cancer
मुख्य लेखकों: Quinn, Casey, Garrison, Louis P, Pownell, Anja K, Atkins, Michael B, de Pouvourville, Gérard, Harrington, Kevin, Ascierto, Paolo Antonio, McEwan, Phil, Wagner, Samuel, Borrill, John, Wu, Elise
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BMJ Publishing Group 2020
विषय:
Position Article and Guidelines
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7359062/
https://ncbi.nlm.nih.gov/pubmed/32661115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000648
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन